The HealthEconomics.Com Newsletter. 07.10.2018. Issue 409

		07.10.2018 Issue 409
Visit HealthEconomics.Com \| Subscribe to Newsletters \| Contact Us \| Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR:		Latest Headlines in HEOR:
Pfizer Delivers Another Round of Price Hikes Thursday, July 5 Pfizer has increased prices on 100 drugs to mark its second round of price hikes this year, according to Fierce Pharma.		Survey: 100% of Respondents Save Money with Value-Based Models ResearchAndMarkets.Com Offers Global HEOR Services Report Report: Look Beyond HIPAA for 21st Century Healthy Information Privacy Article Spotlights Barriers in Big Data, Predictive Analytics ICER Releases Final Report on CGRP Inhibitors for Migraine Prevention MHE Looks at Trump’s Drug Pricing Strategy UDG Healthcare Buys Two U.S. Firms for $82 Million

Associate Research Director-PS8789 Researcher or Senior Researcher-PS8321 Director, HealthCore Biostatistics-PS7682) Research Data Assistant Senior (Data Manager)-PS8215 Research Data Coordinator (Data Manager II)-PS8213 Research Data Manager (PS7307) U.S. Market Access and Contracting Manager Scientific Director, IMEDS		Industry Spotlight

Conferences		Webinars
One-Day Workshop on R for Trial and Model-Based Cost-Effectiveness Analysis July 11, London, U.K. Innovative Strategies for Patient Centered Clinical Research July 11-12, Boston, Massachusetts MedCity CONVERGE July 11-12, Philadelphia, Pennsylvania Health Econometrics Workshop July 16-19, Bergamo, Italy		Improving HCEI Communication: Publication Planning Professionals Are Key Partners in Building Successful HCEI Exchange July 18 Advancing Drug Development and Outcomes Research with Artificial Intelligence, Machine Learning, and Predictive Models July 18 Industry Perceptions and Expectations: The Role of ICER as an Independent HTA July 31

Conference of the Week	Webinar of the Week	Job of the Week	Link of the Week


Syndicated Reports		White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations Paying for Digital Health: Payer Insights Benchmarking Pharma’s MSL Capabilities Biosimilars: U.S. Payer Perspectives KAM Metrics: Driving Efficiency, Measuring Success Biosimilars: E.U. Payer Perspectives MSL Teams: Field Force Size and Structure		Taking a Total View: Linking Pharmacy + Medical Drug Trends Reinventing Claims Payment for a Value-Based World Payers that Engage Members See Better Health Outcomes, Savvier Spending Seeing the Value and Transparency of Medicare Part B A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions Improve Quality Measures with mPulse Mobile Solutions

Special Thanks to Our Partners: